BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8653476)

  • 21. Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin.
    Gottlieb JJ; Washenik K; Chachoua A; Friedman-Kien A
    Lancet; 1997 Nov; 350(9088):1363-4. PubMed ID: 9365453
    [No Abstract]   [Full Text] [Related]  

  • 22. Fatal hepatic failure with liposomal doxorubicin.
    Hengge UR; Brockmeyer NH; Rasshofer R; Goos M
    Lancet; 1993 Feb; 341(8841):383-4. PubMed ID: 8094161
    [No Abstract]   [Full Text] [Related]  

  • 23. DOXIL approved for KS.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):6. PubMed ID: 11363051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasiform pustular eruptions from pegylated-liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
    Kreuter A; Gambichler T; Schlottmann R; Altmeyer P; Brockmeyer N
    Acta Derm Venereol; 2001; 81(3):224. PubMed ID: 11558892
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatic toxicity of liposomal encapsulated doxorubicin.
    Coker RJ; James ND; Stewart JS
    Lancet; 1993 Mar; 341(8847):756. PubMed ID: 8095649
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of liposomal anthracyclines: from basics to clinical applications.
    Gabizon A; Goren D; Cohen R; Barenholz Y
    J Control Release; 1998 Apr; 53(1-3):275-9. PubMed ID: 9741935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
    Amantea MA; Forrest A; Northfelt DW; Mamelok R
    Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxil offers hope to KS sufferers.
    Prescott LM
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):43-4. PubMed ID: 11363097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary Kaposi Sarcoma.
    Gottlieb M
    CJEM; 2016 Sep; 18(5):399-400. PubMed ID: 26791020
    [No Abstract]   [Full Text] [Related]  

  • 30. Penile ulceration during pegylated doxorubicin chemotherapy of classical Kaposi's sarcoma.
    Cannavò SP; Borgia F; Scimone A; Guarneri B
    Acta Derm Venereol; 2009; 89(2):216-7. PubMed ID: 19326025
    [No Abstract]   [Full Text] [Related]  

  • 31. New treatment for KS offers options for therapy.
    AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low to moderate cumulative doses of pegylated liposomal doxorubicin in the treatment of classic Kaposi sarcoma in elderly patients with comorbidities.
    Potouridou I; Korfitis C; Ioannidou D; Polydorou D; Zakopoulou N; Stratigos AJ; Katsambas AD
    Br J Dermatol; 2008 Feb; 158(2):431-2. PubMed ID: 18067475
    [No Abstract]   [Full Text] [Related]  

  • 33. Thoracoscopic sympathectomy for ischaemic lesions related to bleomycin therapy for acquired immune deficiency syndrome-related Kaposi's sarcoma.
    Chakfe N; Rey D; Sibilia J; Bronner JF; Beaufigeau M; Partisani M; Massard G; Lang JM; Wihlm JM; Kretz JG
    Eur J Vasc Endovasc Surg; 1999 Feb; 17(2):175-7. PubMed ID: 10063417
    [No Abstract]   [Full Text] [Related]  

  • 34. Liposomal chemotherapies.
    Smart T
    GMHC Treat Issues; 1995; 9(7/8):13. PubMed ID: 11362653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KS: a new drug and, maybe, a new bug.
    Gilden D
    GMHC Treat Issues; 1995 Jan; 9(1):11-12. PubMed ID: 11367378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
    Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerance of liposomal daunorubicin in Kaposi sarcoma associated with human immunodeficiency virus infection.
    Fournier S; Dupont B; Pialoux G; Eliaszewicz M; Gonzalez-Canali G; Feuillie V
    Arch Dermatol; 1997 Jul; 133(7):918-9. PubMed ID: 9236538
    [No Abstract]   [Full Text] [Related]  

  • 38. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
    Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete remission of a case of classical Kaposi's sarcoma with liposomal doxorubicin and radiotherapy.
    Ezquerra GM; Redonnet MS; Cuchillero RO; Millet PU
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):901-2. PubMed ID: 16898935
    [No Abstract]   [Full Text] [Related]  

  • 40. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma.
    Harrison M; Tomlinson D; Stewart S
    J Clin Oncol; 1995 Apr; 13(4):914-20. PubMed ID: 7707119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.